Menu

Filtros : "Laurindo, I." Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Trabalho de evento-resumo periodico

    Incidence of serious adverse events in patients with rheumatoid arthritis exposed to biologic therapies: results from BiobadaBrasil registry (2016)

    Ranza, R.; Laurindo, I.; Titton, D.; Bertolo, M.; Bianchi, W.; Brenol, C.; Bustamante, M.; Carvalho, H.; Castro, G.; Louzada Júnior, Paulo

    Source: Annals of the Rheumatic Diseases. Conference titles: Annual European Congress of Rheumatology (EULAR). Unidade: FMRP

    Assunto: ARTRITE REUMATOIDE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RANZA, R. et al. Incidence of serious adverse events in patients with rheumatoid arthritis exposed to biologic therapies: results from BiobadaBrasil registry. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1136/annrheumdis-2016-eular.1560. Acesso em: 16 maio 2024. , 2016

    • APA

      Ranza, R., Laurindo, I., Titton, D., Bertolo, M., Bianchi, W., Brenol, C., et al. (2016). Incidence of serious adverse events in patients with rheumatoid arthritis exposed to biologic therapies: results from BiobadaBrasil registry. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1136/annrheumdis-2016-eular.1560

    • NLM

      Ranza R, Laurindo I, Titton D, Bertolo M, Bianchi W, Brenol C, Bustamante M, Carvalho H, Castro G, Louzada Júnior P. Incidence of serious adverse events in patients with rheumatoid arthritis exposed to biologic therapies: results from BiobadaBrasil registry [Internet]. Annals of the Rheumatic Diseases. 2016 ; 75 422.[citado 2024 maio 16 ] Available from: https://doi.org/10.1136/annrheumdis-2016-eular.1560

    • Vancouver

      Ranza R, Laurindo I, Titton D, Bertolo M, Bianchi W, Brenol C, Bustamante M, Carvalho H, Castro G, Louzada Júnior P. Incidence of serious adverse events in patients with rheumatoid arthritis exposed to biologic therapies: results from BiobadaBrasil registry [Internet]. Annals of the Rheumatic Diseases. 2016 ; 75 422.[citado 2024 maio 16 ] Available from: https://doi.org/10.1136/annrheumdis-2016-eular.1560

  • Artigo de periodico

    PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway (2011)

    Oxer, D. S.; Bonfá, E.; Borba, E. F.; Godoy, L. C.; Salgado, T. Lima; Passos, L. A.; Laurindo, I.; Kubo, S.; Barbeiro, D. F.; Laurindo, F. R.; Velasco, I. T.; Curi, Rui; Souza, H. P.

    Source: Lupus. Unidades: FM, ICB

    Subjects: AUTOIMUNIDADE, LÚPUS ERITEMATOSO SISTÊMICO, CITOCINAS, INFLAMAÇÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      OXER, D. S. et al. PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus, v. 20, n. 6, p. 575-587, 2011Tradução . . Disponível em: https://doi.org/10.1177/0961203310392419. Acesso em: 16 maio 2024.

    • APA

      Oxer, D. S., Bonfá, E., Borba, E. F., Godoy, L. C., Salgado, T. L., Passos, L. A., et al. (2011). PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus, 20( 6), 575-587. doi:10.1177/0961203310392419

    • NLM

      Oxer DS, Bonfá E, Borba EF, Godoy LC, Salgado TL, Passos LA, Laurindo I, Kubo S, Barbeiro DF, Laurindo FR, Velasco IT, Curi R, Souza HP. PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway [Internet]. Lupus. 2011 ; 20( 6): 575-587.[citado 2024 maio 16 ] Available from: https://doi.org/10.1177/0961203310392419

    • Vancouver

      Oxer DS, Bonfá E, Borba EF, Godoy LC, Salgado TL, Passos LA, Laurindo I, Kubo S, Barbeiro DF, Laurindo FR, Velasco IT, Curi R, Souza HP. PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway [Internet]. Lupus. 2011 ; 20( 6): 575-587.[citado 2024 maio 16 ] Available from: https://doi.org/10.1177/0961203310392419
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024